{"nctId":"NCT00708097","briefTitle":"In Situ Caries Efficacy of Fluoride Toothpastes","startDateStruct":{"date":"2008-04"},"conditions":["Caries"],"count":57,"armGroups":[{"label":"NaF toothpaste(1450 ppmF)","type":"EXPERIMENTAL","interventionNames":["Drug: NaF"]},{"label":"NaF toothpaste (1400 ppmF)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: NaF"]},{"label":"NaMFP/NaF toothpaste (1450 ppmF)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: NaF","Drug: NaMFP"]},{"label":"NaF toothpaste (675 ppmF)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: NaF"]},{"label":"Placebo toothpaste (0 ppmF)","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"NaF","otherNames":["Fluoride"]},{"name":"Placebo","otherNames":[]},{"name":"NaMFP","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Consent:Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.\n* Age:Aged between 18 and 80 years.\n* Compliance:Understands and is willing, able and likely to comply with all study procedures and restrictions.\n* General Health:Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or physical examination.\n* Fluoride:Currently living in the Indianapolis, Indiana area and not taking fluoride supplements for medical reasons\n* Dentures: a)Currently wearing a removable mandibular partial denture with sufficient room in both posterior buccal flange areas to accommodate two enamel specimens on each side, four specimens in total - required dimensions 12 x 7 millimeter (mm) per side. b) Willing to have their denture modified to accommodate enamel test specimens and willing and capable of wearing their removable mandibular partial dentures 24 hours per day during the experimental periods\n* Dental health: Have no current active caries or periodontal disease that may compromise the study or the health of the subjects and all restorations in a good state of repair\n* Salivary flow:Have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate = 0.2 milliliter (mL)/minute; gum base stimulated whole saliva flow rate = 0.8 mL/minute)\n\nExclusion Criteria:\n\n* Pregnancy: Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.\n* Breast-feeding:Women who are breast-feeding.\n* Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.\n* Antibiotics: Currently taking antibiotics or have taken antibiotics in the two weeks prior to the screening visit\n* Clinical Study/Experimental Medication: a) Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.b) Participation in another GSKCH investigational dental product study within 7 days of first study treatment c)Previous participation in this study.\n* Substance abuse: Recent history (within the last year) of alcohol or other substance abuse.\n* Personnel:a) A member of the site study staff living in same household.b)An employee of the sponsor. c) Any employee of any toothpaste manufacturer or their spouse or family member","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage Surface Microhardness Recovery (%SMHR) of Sound Enamel Specimens Exposed to NaF Toothpaste (1450ppmF) and NaF Toothpaste (1400ppmF)","description":"SMH test was used to assess mineral status of partially demineralized enamel specimens using Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening/demineralization while decrease in the indentation represents rehardening/ remineralization of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline(B); after intra-oral exposure(R) on Day 14; and after in-vitro demineralization(D) on Day 14 using formula \\[(D-R)/(D-B)\\]\\*100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.31","spread":"5.54"},{"groupId":"OG001","value":"26.32","spread":"5.51"}]}]}]},{"type":"SECONDARY","title":"Percentage SMHR of Sound Enamel Specimens Exposed to NaF Toothpaste (1450ppmF), NaF Toothpaste (1400ppmF), NaMFP/NaF Toothpaste (1450ppmF), NaF Toothpaste (675ppmF) and Placebo Toothpaste (0ppmF)","description":"SMH test was used to assess mineral status of partially demineralized enamel specimens using Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening/demineralization while decrease in the indentation represents rehardening/ remineralization of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline(B); after intra-oral exposure(R) on Day 14; and after in-vitro demineralization(D) on Day 14 using formula \\[(D-R)/(D-B)\\]\\*100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.31","spread":"5.54"},{"groupId":"OG001","value":"26.32","spread":"5.51"},{"groupId":"OG002","value":"26.13","spread":"5.49"},{"groupId":"OG003","value":"25.52","spread":"5.48"},{"groupId":"OG004","value":"53.38","spread":"5.52"}]}]}]},{"type":"SECONDARY","title":"Percentage SMHR of Demineralized Enamel Specimens Exposed to NaF Toothpaste (1450ppmF), NaF Toothpaste (1400ppmF), NaF Toothpaste (675ppmF), NaMFP/NaF Toothpaste(1450ppmF) and Placebo Toothpaste (0ppmF)","description":"SMH test was used to assess mineral status of partially demineralized enamel specimens using Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening/demineralization while decrease in the indentation represents rehardening/ remineralization of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline(B); after intra-oral exposure(R) on Day 14; and after in-vitro demineralization(D) on Day 14 using formula \\[(D-R)/(D-B)\\]\\*100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34.62","spread":"2.82"},{"groupId":"OG001","value":"36.06","spread":"2.79"},{"groupId":"OG002","value":"31.12","spread":"2.77"},{"groupId":"OG003","value":"27.15","spread":"2.77"},{"groupId":"OG004","value":"11.10","spread":"2.80"}]}]}]},{"type":"SECONDARY","title":"Enamel Fluoride Uptake (Sound Enamel Specimens)","description":"Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride (F) divided by the area of the enamel cores. The difference between treatments was calculated with respect to fluoride uptake by enamel.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"648.06","spread":"47.10"},{"groupId":"OG001","value":"650.07","spread":"46.30"},{"groupId":"OG002","value":"541.16","spread":"45.91"},{"groupId":"OG003","value":"487.14","spread":"45.86"},{"groupId":"OG004","value":"425.59","spread":"46.67"}]}]}]},{"type":"SECONDARY","title":"Enamel Fluoride Uptake (Demineralized Specimens)","description":"Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride (F) divided by the area of the enamel cores. The difference between treatments was calculated with respect to fluoride uptake by enamel.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2499.47","spread":"133.46"},{"groupId":"OG001","value":"2513.37","spread":"131.09"},{"groupId":"OG002","value":"1923.76","spread":"129.91"},{"groupId":"OG003","value":"1861.80","spread":"129.78"},{"groupId":"OG004","value":"686.18","spread":"132.20"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Gingival erythema"]}}}